Double Medical Technology Hits Day Low of CNY 40.20 Amid Price Pressure

Double Medical Technology, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 4.78% on March 23, 2026. The stock reached an intraday low of CNY 40.20, reflecting a challenging trading day for the company. Over the past week, Double Medical has seen a decrease of 9.82%, and its performance over the last month has dropped by 14.51%. Despite these short-term setbacks, the company has demonstrated resilience with a year-to-date performance of -14.27%, which still outpaces the China Shanghai Composite's decline of 3.92%. In terms of financial health, Double Medical reported a significant net profit growth of 27.79% as of September 25, and it has consistently delivered positive results for five consecutive quarters. The company boasts a robust operating cash flow of CNY 710.24 million and a return on capital employed (ROCE) of 16.66%. With a market capitalization of CNY 16,653 million, Double Medical continues to maintain a strong position within its industry, despite the recent fluctuations in its stock price.